secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001193125-25-117771
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Royalty Pharma shareholders approve internalization deal; all director nominees elected
--------------------------------------------------------------------------------

- Proposal 2 (Membership Interest Purchase Agreement internalization) approved with 440.5M For, 74K Against.
- All nine director nominees elected, including Pablo Legorreta, Henry Fernandez, Bonnie Bassler.
- Advisory say-on-pay (Proposal 7) passed with 403.2M For, 36.8M Against.
- Appointment of Ernst & Young as auditor ratified with 493.5M For, 116K Against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000119312525117771/0001193125-25-117771-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000119312525117771/d52049d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-117771

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer